FDA Clearance Tracker · P100006
AUGMENT BONE GRAFT
Last checked: Nov 19, 2026Latest source record: Sep 1, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Sep 1, 2015
Approved
Time to decision
2,035 days
Received Feb 4, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P100006
- Device name
- AUGMENT BONE GRAFT
- Applicant
- Biomimetic Therapeutics, LLC
- Applicant location
- Franklin, TN
- Received
- Feb 4, 2010
- Decided
- Sep 1, 2015
- Decision
- Approved
- Supplements
- 12 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Filler, bone void, synthetic peptide (NOX)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AUGMENT® BONE GRAFT. THIS DEVICE IS INDICATED FOR USE AS AN ALTERNATIVE TO AUTOGRAFT IN ARTHRODESIS (I.E., SURGICAL FUSION PROCEDURES) OF THE ANKLE (TIBIOTALAR JOINT) AND/OR HINDFOOT (INCLUDING SUBTALAR, TALONAVICULAR, AND CALCANEOCUBOID JOINTS, ALONE OR IN COMBINATION), DUE TO OSTEOARTHRITIS, POST-TRAUMATIC ARTHRITIS, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AVASCULAR NECROSIS, JOINT INSTABILITY, JOINT DEFORMITY, CONGENITAL DEFECT, OR JOINT ARTHROPATHY IN PATIENTS WITH PREOPERATIVE OR INTRAOPERATIVE EVIDENCE INDICATING THE NEED FOR SUPPLEMENTAL GRAFT MATERIAL.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NOX (Filler, bone void, synthetic peptide).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Biomimetic Therapeutics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AUGMENT INJECTABLEPMA supplement
P100006-S005 · Decided Jun 12, 2018 · 589 days after receipt · Panel Track
Device type: Filler, bone void, synthetic peptide (NOX) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.